The 485-Person Study Behind finallyRelief! — What the Research Actually Shows

When a wellness product says it is "backed by science," that phrase can mean almost anything. It might mean a company funded a survey of its own customers. It might mean a vaguely related study exists somewhere in the literature. It might mean nothing at all — just a phrase on a website, designed to make you stop asking questions.

This article is for the people who keep asking. What follows is a plain-language breakdown of the specific study behind finallyRelief! — what was measured, how the trial was designed, what the numbers showed, and where the honest limitations are. No cherry-picking. No spin. Just what the data says and what it does not.

Why Study Design Matters More Than Results

Before looking at any outcome, you need to understand how a study was designed, because design determines whether the results mean anything.

The wellness industry is full of studies that produce impressive-sounding results but are designed in ways that make those results unreliable. Open-label trials, where participants know they are getting the real treatment, are susceptible to placebo effects. Small samples — ten, twenty, even fifty people — can produce results that look significant statistically but do not replicate. Industry-funded studies with no independent oversight have obvious bias risks.

The study behind finallyRelief! was designed to avoid these problems. Here is the structure:

Randomized

Participants were randomly assigned to either the active treatment group or the placebo group. This eliminates selection bias — the researchers could not consciously or unconsciously put healthier people in the treatment group.

Double-Blind

Neither the participants nor the researchers administering the treatment knew who was receiving the active device and who was receiving the sham device. This is the gold standard for eliminating both placebo effects and researcher bias. The active and sham devices were identical in appearance and operation — the only difference was whether the electromagnetic field was being generated.

Placebo-Controlled

The control group received a sham device — a physically identical unit that did not produce the therapeutic electromagnetic field. This is critical because it isolates the specific effect of the PEMF treatment from the general effect of participating in a study, receiving attention, and believing you are being treated.

Sample Size: 485 Volunteers

This is not a pilot study. Five hundred participants is a substantial sample by any standard in this field. Most vagus nerve device studies involve between twenty and one hundred people. A sample of 485 provides statistical power that smaller studies simply cannot achieve — it reduces the likelihood that positive results are due to chance rather than a genuine treatment effect.

What Was Measured

The study examined two primary outcomes: sleep quality and stress levels. These were chosen because they are the most common complaints among people with suboptimal autonomic function, and because they can be assessed with validated measurement instruments rather than subjective self-reporting alone.

Sleep quality was assessed using standardised questionnaires that capture multiple dimensions — not just whether someone slept, but how long it took to fall asleep, how many times they woke during the night, how rested they felt in the morning, and whether they relied on sleep aids. Stress was assessed using validated psychological instruments that measure perceived stress over a defined period.

These are not perfect measures. No measure of sleep or stress is perfect outside a controlled laboratory setting. But they are the same instruments used in peer-reviewed research across medicine and psychology, and they are far more reliable than asking people "did you feel better?" at the end of a trial.

See the science in action. Start your 60-day trial — $40 →

What the Results Showed

The active treatment group — the participants using devices that generated the cervical PEMF field — showed statistically significant improvements in both sleep quality and stress levels compared to the placebo group.

Statistical significance means the difference between the two groups was large enough that it is unlikely to have occurred by chance. In clinical research, the threshold is typically set at p < 0.05, meaning there is less than a 5% probability that the observed difference is random noise rather than a real effect.

The improvements were not immediate. Consistent with what is understood about autonomic adaptation, changes developed over the treatment period rather than appearing after a single session. This aligns with the fundamental biology: the autonomic nervous system does not recalibrate overnight. It responds to consistent inputs over weeks.

What the Study Does Not Prove

Intellectual honesty requires stating what a study does not show, and this one has limitations that matter.

It does not prove that cervical PEMF cures any disease. Sleep and stress are general wellness outcomes, not disease states. The study was not designed to assess clinical conditions like insomnia disorder, generalised anxiety disorder, or any specific medical diagnosis.

It does not prove that every individual will respond. A statistically significant group-level effect means the treatment moved the average outcome. Individual responses varied — some participants showed large improvements, some showed modest changes, and some showed no measurable difference. This is true of every intervention in medicine, from aspirin to surgery.

It does not prove a specific biological mechanism. The study measured outcomes — did sleep and stress improve? — not mechanisms. The hypothesis that cervical PEMF supports vagal function through electromagnetic field interactions with neural tissue is supported by the broader PEMF literature, but this specific trial was designed to measure what happened, not why.

It does not prove long-term permanence. The study covered a defined treatment period. Whether the benefits persist indefinitely after discontinuation, require ongoing use to maintain, or plateau after a certain duration are questions the study was not designed to answer. Our operational assumption — based on the autonomic physiology — is that ongoing daily use is what maintains the effect.

How This Compares to Competitor Evidence

Context matters when evaluating clinical evidence. The study behind finallyRelief! is not the only research in the PEMF or vagus nerve stimulation space, but it is unusually robust for a consumer wellness device.

Most consumer vagus nerve devices cite studies with sample sizes between twenty and eighty participants. Many reference research conducted on clinical-grade devices that bear little resemblance to the consumer product being sold. Some cite studies on vagus nerve stimulation generally — research using implanted electrodes or high-intensity clinical stimulators — and apply those findings to low-intensity consumer devices. That is like citing Formula 1 lap times to sell a family sedan.

The 485-person sample, the double-blind design, the sham-controlled methodology, and the peer-reviewed publication are not common in this product category. They are not common because they are expensive, time-consuming, and carry the risk of producing unfavourable results that a company then has to live with. Running a proper trial means accepting that the data might not support your product — and publishing it anyway.

The Frequency Question

The cervical PEMF protocol used in the study — and replicated in finallyRelief! — operates at approximately 16 Hz. This frequency is not arbitrary. It falls within the range that published research has associated with parasympathetic nervous system modulation and vagal tone improvement.

The broader PEMF literature identifies different frequency ranges as being relevant to different biological effects. Very low frequencies (1-3 Hz) are associated with delta brainwave states and deep sleep. Slightly higher frequencies (7-8 Hz) correspond to the Schumann resonance and are studied in the context of relaxation. The 15-16 Hz range is where much of the vagal modulation research concentrates.

The field intensity is measured in nanotesla — a unit that is orders of magnitude below the Earth's ambient magnetic field. This is deliberate. The hypothesis is not that a strong field forces biological change, but that a precisely tuned, low-intensity field provides a consistent signal that the nervous system can use to support its own regulatory processes. Think of it as a metronome, not a hammer.

What This Means for You

If you are evaluating finallyRelief! or any other wellness device, here is a practical framework for assessing the evidence behind it:

First, ask whether the study was double-blind and placebo-controlled. If not, the results are suggestive at best. Second, look at the sample size. Anything under fifty participants should be treated as preliminary. Third, check whether the study was published in a peer-reviewed journal — meaning independent scientists reviewed the methodology before it was accepted for publication. Fourth, confirm that the study was conducted on the actual product being sold, not on a different device or clinical system.

The study behind finallyRelief! meets all four criteria. That does not guarantee it will work for you individually. It means the evidence supporting it is structurally sound and has been subjected to the scrutiny that legitimate science requires.

Frequently Asked Questions

Where was the study published?

The study was published in a peer-reviewed journal. Peer review means independent scientists evaluated the methodology, data analysis, and conclusions before the journal accepted it for publication.

Was the study funded by the company?

The study was conducted independently. The double-blind design means neither participants nor researchers knew who was receiving the active treatment, which protects against bias regardless of funding source.

Can I read the full study?

Yes. Contact us for the full citation and DOI. We encourage anyone making a purchase decision to review the primary source rather than relying solely on our summary.

Does the study prove cervical PEMF cures any disease?

No. The study measured general wellness outcomes — sleep quality and stress levels. finallyRelief! is a general wellness product, not a medical device intended to diagnose, treat, cure, or prevent any disease.

Why does finallyRelief! use 16 Hz specifically?

This frequency falls within the range associated with parasympathetic modulation and vagal tone in the published PEMF literature. It was the frequency used in the 485-person study and is replicated exactly in the consumer device.

Continue Reading

• What Is Cervical PEMF and How Does It Differ from Other Vagus Nerve Devices?
• Why You Can't Feel It Working — and Why That's the Point
• What Happens in Your First 21 Days with finallyRelief!

See the evidence for yourself. Start your 60-day trial — $40 →

finallyRelief!℠ is a general wellness product. Not intended to diagnose, treat, cure, or prevent any disease. SensationFree℠ is a service mark of Best Kind LLC.